Plain-English translation of NCT06361095 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Depression research guide โPhase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This trial is testing a new approach to treating depression using attention bias modification (ABM)โa program that helps retrain where your eyes look when you see different images. The study compares three versions: a gamified mobile app version (like a game on your phone), a traditional computer-based version, and a placebo version. Researchers want to see which approach works best at reducing depression symptoms.
Depression is common and can be hard to treat with medication alone. Early research suggests that people with depression tend to focus more on sad or negative images, and retraining this attention pattern might help improve mood. This trial will test whether this new treatment approach actually works for reducing depression in a large group of people.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to use either the mobile app version, the computer version, or a placebo version of the attention retraining program. You'll complete the program on your own device over a period of time, with regular check-ins where researchers will measure your depression symptoms using questionnaires and interviews. The study involves 600 participants total, so you'll be part of a large group helping researchers understand whether this treatment approach works.
AI-generated summary from trial data ยท Jun 5, 2026 ยท Not medical advice
United States